Recent use of oral contraceptives and the risk of multiple sclerosis

Archives of Neurology

Volumn 62, Issue 9, 2005, Pages 1362-1365

  Alonso, Álvaro ^a   Jick, Susan S ^c   Olek, Michael J ^d   Ascherio, Alberto ^a,b   Jick, Hershel ^c   Hernán, Miguel A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; FEMALE; GENERAL PRACTITIONER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PARITY; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOM;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HEALTH CARE SURVEYS; HUMANS; LONGITUDINAL STUDIES; MULTIPLE SCLEROSIS; PREGNANCY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; TIME FACTORS;

EID: 25144463912     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.9.1362     Document Type: Article

References (21)

1. Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol. 2003;176:293-304.
2. Jansson L, Olsson T, Holmdahl R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol. 1994;53:203-207.
3. Subramanian S, Matejuk A, Zamora A, Vandenbark AA, Offner H. Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J Immunol. 2003;170:1548-1555.
4. Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology. 1999;52:1230-1238.
5. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T; Pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998;339:285-291.
6. Villard-Mackintosh L, Vessey MP. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception. 1993;47:161-168.
7. Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol. 1998;105:1296-1299.
8. Hernán MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology. 2000;55:848-854.
9. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998;45:419-425.
10. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991;302:766-768.
11. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the General Practice Research Database. Pharmacotherapy. 2003;23:686-689.
12. Hernán MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2004;63:838-842.
13. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
14. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-127.
15. + T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol. 1998;161:3365-3374.
16. Drew PD, Chavis JA, Bhatt R. Sex steroid regulation of microglial cell activation: relevance to multiple sclerosis. Ann N Y Acad Sci. 2003;1007:329-334.
17. Dietrich JB. Endothelial cells of the blood-brain barrier: a target for glucocorticoids and estrogen? Front Biosci. 2004;9:684-693.
18. Takao T, Flint N, Lee L, Ying X, Merrill J, Chandross KJ. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem. 2004;89:660-673.
19. Gilmore W, Arias M, Stroud N, Stek A, McCarthy KA, Correale J. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci. 2004;224:69-76.
20. Antonovsky A, Leibowitz U, Smith HA, et al. Epidemiologic study of multiple sclerosis in Israel, I: an overall review of methods and findings. Arch Neurol. 1965;13:183-193.
21. Operskalski EA, Visscher BR, Malmgrem RM, Detels R. A case-control study of multiple sclerosis. Neurology. 1989;39:825-829.